Navigation Links
OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
Date:2/14/2008

PORTLAND, Ore. An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a mans prostate cancer is going to come back after surgical removal.

In order to make this discovery, researchers examined prostate cancer tissue samples that had been removed during surgical procedures on cancer patients. The researchers found that men whose tumors showed a silencing of the gene CDH13 had a five-fold increased risk of prostate cancer recurrence compared with men whose tumors showed no silencing of this gene, according to Joshi Alumkal, M.D., OHSU Cancer Institute member and assistant professor of medicine, (hematology/medical oncology), OHSU School of Medicine. In normal cells, this gene is active, but in some cancer cells it may be turned off, which leads to a propensity for metastasis, or spreading.

The research, DNA Methylation as a Predictor of Prostate Cancer Recurrence, will be presented as a poster on Thursday, Feb. 14, from 11:30 a.m. to 12:30 p.m. at the 2008 American Society of Clinical Oncology Genitourinary Symposium in San Francisco.

In this study, the largest of its kind examining DNA methylation changes and prostate cancer recurrence, the research team looked at tissue samples from 151 research subjects with localized prostate cancer with at least five years of follow-up after their prostatectomies. During prostate cancer formation, the DNA may be modified through a process called DNA methylation, which turns off many important genes called tumor suppressor genes that act as the brakes on cancer cell growth or cancer cell spread. CDH13 is a prime example of one of these genes.

Two-thirds of the subjects were free of recurrence; one-third had a recurrence.

In the clinic, those of us who care for patients with prostate cancer look at the pathology report and PSA blood test to determine how a patient will do after surgery and how aggr
'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-6397
Oregon Health & Science University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. DDT Compound Speeds Breast Cancer Growth
2. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
3. The Facts African Americans Need to Know About Colon Cancer
4. How DDT metabolite disrupts breast cancer cells
5. Climb to Fight Breast Cancer Offers Peaks for Every Skill Level
6. Patient with rare disorder responds to cancer drug
7. Cancer Drug Works Against MS in Early Trial
8. American Cancer Society honors exemplary cancer caregivers
9. Smokers might benefit from earlier colon cancer screening
10. Scientists solve structure of gene regulator that plays key role in cancer
11. Sun Busters(R) Now Sports The Skin Cancer Foundations Seal of Recommendation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...rding the treatment of AIDS/HIV infection that has...f a global research, AIDS still remains a puzzle t...nt of patients with HIV, or human immunodeficiency...very slowly.// Past research suggested that such ...
...s who make fewer visits to the dentists than their... the fact that smoking puts them more at risk from...holds true regardless of age, gender, race, ethnic..., location and insurance coverage. The study, repo...
...sity College of Medicine and Public Health had fou...esponding well to other treatments might be treate...NS) with significantly better results.// As an al...pproved the implantation of a vagus nerve stimulat...
...ch the oxygen-carrying protein in the red blood ce...ickled) shape that can disrupt circulation, leadin...es fatal complications. // "Sickle cell anemia is...disables children as they grow," according to Dr.W...
Other Medicine News:Health News:Study holds promise for new way to fight HIV 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:7/22/2008)...alidated by Columbia University Medical Center Bas...oRNA Technology, The Test Differentiates Squamou...SCLC), Classifying Squamous-Cell Carcinoma of the ...cificity of 90 Percent,This is the First CLIA Appr... as Biomarkers for Accurate Diagnosis of Lu...
(Date:7/22/2008)...ests That Ekkyo,s New Approach of LASH (Laser Assi...r Healing Physiology, MARSEILLES, France, July 22... Technology) a photomedicine company, which develo...r prevention and reduction, announced today,the pu...gery and Medicine*,reporting the results of a pilo...
(Date:7/21/2008).../- The SEAS (Simvastatin and Ezetimib...ffects of intensive,cholesterol lowering with the ...mibe (10 mg daily) in patients with aortic stenosi...age of the aortic valve in,the heart) is a relativ...opulations. Left untreated, it can progress to dea...
(Date:7/21/2008)...profile helps clinicians identify risk in patients...evels and statin therapy, BIRMINGHAM, Ala., July ...from Atherotech, researchers have identified a lin...n. The information could help,physicians trying to...,disease risk-lowering treatments in at-risk patie...
Breaking Medicine Technology:First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 1Natural Solutions May Issue Illustrates Cocktail Effect of Everyday Toxins 3B Offers Tips to Reduce Toxic Load 18746 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 1Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 2Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 3Human Genome Sciences Appoints John L Lamattina Ph D to Its Board of Directors 18743 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 1Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 3Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 5Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 6Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 7Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5211 8Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 1Anacor to Present Clinical and Preclinical Data on Topical Anti Inflammatory Candidates AN2728 and AN2898 at the International Investigative Dermato 5208 2